Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Dow
Johnson and Johnson
Deloitte
Fuji
Queensland Health
UBS
Express Scripts
Teva
US Department of Justice

Generated: October 19, 2017

DrugPatentWatch Database Preview

Dentsply Pharm Company Profile

« Back to Dashboard

What is the competitive landscape for DENTSPLY PHARM, and when can generic versions of DENTSPLY PHARM drugs launch?

DENTSPLY PHARM has eight approved drugs.

There is one US patent protecting DENTSPLY PHARM drugs.

There are thirty-two patent family members on DENTSPLY PHARM drugs in twenty-nine countries.

Summary for Applicant: Dentsply Pharm

International Patents:32
US Patents:1
Tradenames:8
Ingredients:8
NDAs:8
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dentsply Pharm
POLOCAINE
mepivacaine hydrochloride
INJECTABLE;INJECTION088653-001Aug 21, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Dentsply Pharm
DURANEST
epinephrine bitartrate; etidocaine hydrochloride
INJECTABLE;INJECTION021384-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Dentsply Pharm
XYLOCAINE DENTAL WITH EPINEPHRINE
epinephrine; lidocaine hydrochloride
INJECTABLE;INJECTION021381-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Dentsply Pharm
XYLOCAINE DENTAL
lidocaine hydrochloride
INJECTABLE;INJECTION021380-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Dentsply Pharm
ORAQIX
lidocaine; prilocaine
GEL;PERIODONTAL021451-001Dec 19, 2003RXYesYes► Subscribe► SubscribeY ► Subscribe
Dentsply Pharm
XYLOCAINE DENTAL WITH EPINEPHRINE
epinephrine; lidocaine hydrochloride
INJECTABLE;INJECTION021381-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Dentsply Pharm
CITANEST PLAIN DENTAL
prilocaine hydrochloride
INJECTABLE;INJECTION021382-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Dentsply Pharm
CITANEST FORTE DENTAL
epinephrine bitartrate; prilocaine hydrochloride
INJECTABLE;INJECTION021383-001Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe
Dentsply Pharm
POLOCAINE W/ LEVONORDEFRIN
levonordefrin; mepivacaine hydrochloride
INJECTABLE;INJECTION089517-001Apr 14, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Dentsply Pharm

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Dentsply Pharm
ORAQIX
lidocaine; prilocaine
GEL;PERIODONTAL021451-001Dec 19, 2003► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Dentsply Pharm Drugs

Country Document Number Estimated Expiration
Australia2416897► Subscribe
Sweden9601421► Subscribe
China1149072► Subscribe
Hungary9903544► Subscribe
JapanH11501678► Subscribe
South Africa9703022► Subscribe
Brazil9702147► Subscribe
Taiwan473386► Subscribe
Austria248584► Subscribe
Turkey9701584► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
Merck
US Department of Justice
McKesson
Queensland Health
QuintilesIMS
Dow
Citi
Daiichi Sankyo
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot